Trials / Completed
CompletedNCT02510820
The Clinical Performance of the Biofinity Contact Lens (Comfilcon A) With Two Lens Care Systems
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- CooperVision, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This will be a controlled and randomized, single-masked, crossover study in which 48 subjects will use the Biofinity Contact Lens (comfilcon A) with each of the two lens care products ('solutions'), (Synergi and Biotrue Multi-purpose Solution) for one month each. Follow-up visits for each solution will take place at one week, two weeks and four weeks: with a one-week 'wash-out' period between the solutions. Key outcome measures for this study include biomicroscopic and subjective responses to the lens/solution combinations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | comfilcon A | soft contact lens |
| DEVICE | Synergi | Multipurpose solution |
| DEVICE | Biotrue | Multipurpose solution |
| OTHER | stenfilcon A | daily disposable contact lenses for washout period |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2015-09-01
- Completion
- 2015-10-01
- First posted
- 2015-07-29
- Last updated
- 2017-02-01
- Results posted
- 2017-02-01
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02510820. Inclusion in this directory is not an endorsement.